# To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe

> **NCT04732793** · NA · COMPLETED · sponsor: **LG Chem** · enrollment: 284 (actual)

## Conditions studied

- Osteoarthritis (OA) of the Knee

## Interventions

- **DEVICE:** Hyruan ONE®
- **DEVICE:** Durolane®

## Key facts

- **NCT ID:** NCT04732793
- **Lead sponsor:** LG Chem
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-03
- **Primary completion:** 2021-06-11
- **Final completion:** 2021-12-07
- **Target enrollment:** 284 (ACTUAL)
- **Last updated:** 2022-03-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04732793

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04732793, "To Assess the Safety and Effectiveness of Hyruan ONE Versus a Comparator for the Treatment of Knee Osteoarthritis in Europe". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04732793. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*